Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04628442 · ClinicalTrials.gov registry record
Tissue Immune Interaction in Nasal Polyposis
A clinical trial of Asthma and Chronic Rhinosinusitis With Nasal Polyps, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 38
- Enrollment target
- 1
- Study location
NCT04628442 is a study of Asthma and Chronic Rhinosinusitis With Nasal Polyps that has completed, run by University of California, San Francisco. The registered enrollment target is 38 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04628442, a study of Asthma and Chronic Rhinosinusitis With Nasal Polyps, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a cross-sectional study of up to 100 subjects who are undergoing clinically indicated sinus procedures to treat chronic rhinosinusitis. Participants will be asked to donate leftover sino-nasal secretions, sino-nasal tissue and blood as well as undergo partial characterization. As optional extensions of the main study, participants may also undergo a biopsy of extra sino-nasal tissue for additional tissue analysis and/or a more detailed characterization visit performed in the UCSF Airway Center Research Center (ACRC).
Conditions Studied
Interventions
- PROCEDURE Biopsy
- PROCEDURE Sinonasal Debridement Procedure
- PROCEDURE Nasal Polyp Removal
Study Locations (1)
California
- UCSF Airway Clinical Research Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-11-10 |
| Est. Completion | 2023-03-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04628442
The ClinicalTrials.gov registry entry for NCT04628442 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which Biopsy is the first listed.
NCT04628442 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04628442 about?
NCT04628442 is a clinical study titled "Tissue Immune Interaction in Nasal Polyposis". This is a cross-sectional study of up to 100 subjects who are undergoing clinically indicated sinus procedures to treat chronic rhinosinusitis. Participants will be asked to donate leftover sino-nasal secretions, sino-nasal tissue and blood as well as undergo partial characterization. As optional ex...
What is the current status of trial NCT04628442?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2020-11-10. Estimated completion is 2023-03-24.
What conditions does trial NCT04628442 study?
This clinical trial studies the following conditions: Asthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis).
What interventions are being tested in trial NCT04628442?
The interventions under investigation include: Biopsy (PROCEDURE), Sinonasal Debridement Procedure (PROCEDURE), Nasal Polyp Removal (PROCEDURE).
Who is sponsoring clinical trial NCT04628442?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04628442 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.